相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Cholecalciferol (Vitamin D3) Therapy and Vitamin D Insufficiency in Patients with Chronic Kidney Disease: A Randomized Controlled Pilot Study
Prakash Chandra et al.
Endocrine Practice (2013)
Randomized Trial Assessing the Effects of Ergocalciferol Administration on Circulating FGF23
Sherri-Ann M. Burnett-Bowie et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2012)
Vitamin D deficiency is a predictor of reduced survival in patients with heart failure; vitamin D supplementation improves outcome
Israel Gotsman et al.
EUROPEAN JOURNAL OF HEART FAILURE (2012)
Vitamin D Therapy and Cardiac Structure and Function in Patients With Chronic Kidney Disease The PRIMO Randomized Controlled Trial
Ravi Thadhani et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2012)
Low 25-Hydroxyvitamin D Is Associated with Increased Mortality in Female Nursing Home Residents
Stefan Pilz et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2012)
Update on fibroblast growth factor 23 in chronic kidney disease
Myles Wolf
KIDNEY INTERNATIONAL (2012)
2.5-Hydroxyvitamin D deficiency is associated with fatal stroke among whites but not blacks: The NHANES-III linked mortality files
Erin D. Michos et al.
NUTRITION (2012)
REGULATION AND FUNCTION OF THE FGF23/KLOTHO ENDOCRINE PATHWAYS
Aline Martin et al.
PHYSIOLOGICAL REVIEWS (2012)
The role of vitamin D in the FGF23, klotho, and phosphate bone-kidney endocrine axis
Mark R. Haussler et al.
REVIEWS IN ENDOCRINE & METABOLIC DISORDERS (2012)
Vitamin D Status and Mortality Risk in CKD: A Meta-analysis of Prospective Studies
Stefan Pilz et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2011)
Low 25-Hydroxyvitamin D Levels and Mortality in Non-Dialysis-Dependent CKD
Sankar D. Navaneethan et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2011)
20-Hydroxyvitamin D2 is a noncalcemic analog of vitamin D with potent antiproliferative and prodifferentiation activities in normal and malignant cells
Andrzej T. Slominski et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2011)
Vitamin D Supplementation in Chronic Kidney Disease: A Systematic Review and Meta-Analysis of Observational Studies and Randomized Controlled Trials
Praveen Kandula et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2011)
Vitamin D Supplementation for Cardiovascular Disease Prevention
James H. O'Keefe et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2011)
Fibroblast Growth Factor 23 and Risks of Mortality and End-Stage Renal Disease in Patients With Chronic Kidney Disease
Tamara Isakova et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2011)
Evaluation, Treatment, and Prevention of Vitamin D Deficiency: an Endocrine Society Clinical Practice Guideline
Michael F. Holick et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2011)
The 2011 Report on Dietary Reference Intakes for Calcium and Vitamin D from the Institute of Medicine: What Clinicians Need to Know
A. Catharine Ross et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2011)
FGF23 induces left ventricular hypertrophy
Christian Faul et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
Elevated Fibroblast Growth Factor 23 is a Risk Factor for Kidney Transplant Loss and Mortality
Myles Wolf et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2011)
Calcitriol and doxercalciferol are equivalent in controlling bone turnover, suppressing parathyroid hormone, and increasing fibroblast growth factor-23 in secondary hyperparathyroidism
Katherine Wesseling-Perry et al.
KIDNEY INTERNATIONAL (2011)
Vitamin D status and mortality in chronic kidney disease
Stefan Pilz et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2011)
The Associations of Fibroblast Growth Factor 23 and Uncarboxylated Matrix Gla Protein With Mortality in Coronary Artery Disease: The Heart and Soul Study
Benjamin D. Parker et al.
ANNALS OF INTERNAL MEDICINE (2010)
Fibroblast Growth Factor 23 and Disordered Vitamin D Metabolism in Chronic Kidney Disease: Updating the Trade-off Hypothesis
Orlando M. Gutierrez
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2010)
Effects of vitamin D replacement therapy on serum FGF23 concentrations in vitamin D-deficient women in short term
Ayse Kubat Uzum et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2010)
Increased parathyroid expression of klotho in uremic rats
Jacob Hofman-Bang et al.
KIDNEY INTERNATIONAL (2010)
Vitamin D controls T cell antigen receptor signaling and activation of human T cells
Marina Rode von Essen et al.
NATURE IMMUNOLOGY (2010)
Racial differences in postprandial mineral ion handling in health and in chronic kidney disease
Orlando M. Gutierrez et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2010)
PTH increases FGF23 gene expression and mediates the high-FGF23 levels of experimental kidney failure: a bone parathyroid feedback loop
Vardit Lavi-Moshayoff et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2010)
Clinical Outcomes with Active versus Nutritional Vitamin D Compounds in Chronic Kidney Disease
Kamyar Kalantar-Zadeh et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2009)
Vitamin D Affects Survival Independently of Vascular Calcification in Chronic Kidney Disease
Daniela Veit Barreto et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2009)
Nonclassic Actions of Vitamin D
Daniel Bikle
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2009)
Association of oral calcitriol with improved survival in non-dialysed and dialysed patients with CKD
Armando L. Negri
NEPHROLOGY DIALYSIS TRANSPLANTATION (2009)
Monthly cholecalciferol administration in haemodialysis patients: a simple and efficient strategy for vitamin D supplementation
Guillaume Jean et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2009)
Association of activated vitamin D treatment and mortality in chronic kidney disease
Csaba P. Kovesdy et al.
ARCHIVES OF INTERNAL MEDICINE (2008)
Relationship between serum 1,25-dihydroxyvitamin D and mortality in patients with pre-dialysis chronic kidney disease
Daijo Inaguma et al.
CLINICAL AND EXPERIMENTAL NEPHROLOGY (2008)
Hypovitaminosis D in chronic kidney disease
Rajnish Mehrotra et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2008)
Prevalence of vitamin D [25(OH)D] deficiency and effects of supplementation with ergocalciferol (vitamin D2) in stage 5 chronic kidney disease patients
Debra Blair et al.
JOURNAL OF RENAL NUTRITION (2008)
Impact of activated vitamin D and race on survival among hemodialysis patients
Myles Wolf et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2008)
High-dose cholecalciferol to correct vitamin D deficiency in haemodialysis patients
Faruk Tokmak et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2008)
Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis
Orlando M. Gutierrez et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Effect of depot oral cholecalciferol treatment on secondary hyperparathyroidism in stage 3 and stage 4 chronic kidney diseases patients
Ekrem Dogan et al.
RENAL FAILURE (2008)
Fibroblast growth factor 23 (FGF23) predicts progression of chronic kidney disease: The mild to moderate kidney disease (MMKD) study
Danilo Fliser et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2007)
Vitamin D deficiency
Michael F. Holick
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Impact of ergocalciferol treatment of vitamin D deficiency on serum parathyroid hormone concentrations in chronic kidney disease
Anna L. Zisman et al.
AMERICAN JOURNAL OF NEPHROLOGY (2007)
Prevalence of vitamin D deficiency and the safety and effectiveness of monthly ergocalciferol in hemodialysis patients
Georges Saab et al.
NEPHRON CLINICAL PRACTICE (2007)
Effect of ergocalciferol supplementation on serum parathyroid hormone and serum 25-hydroxyvitamin D in chronic kidney disease
Jason DeVille et al.
NEPHROLOGY (2006)
Activated injectable vitamin D and hemodialysis survival:: A historical cohort study
M Teng et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2005)
分享论文
